Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vas Narasimhan
Pharma
Novartis builds momentum with new drug launches
Novartis CEO Vas Narasimhan acknowledged that the company could have made its recent $23 billion U.S. investment plan sooner.
Angus Liu
Apr 29, 2025 10:52am
Sanofi, Novartis CEOs blast EU austerity amid US tariff threat
Apr 23, 2025 12:25am
Novartis unveils $23B investment to beef up US manufacturing, R&D
Apr 10, 2025 3:18pm
Novartis, Roche give their CEOs pay raises in 2024
Feb 19, 2025 10:55am
Kisqali off to a 'very rapid' launch in early breast cancer: CEO
Jan 31, 2025 11:28am
Novartis increases sales growth estimate through 2029
Nov 21, 2024 11:57am
.jpg?VersionId=vm.tXwrjJ5KiGFltY_A28fCoiO3GGtA1)
